ASPG Menu
search

American Scientific Publishing Group

verified Journal

Metaheuristic Optimization Review

ISSN
Online: 3066-280X
Frequency

Continuous publication

Publication Model

Open access · Articles freely available online · No author fees or charges

Metaheuristic Optimization Review
Review Article

Volume 7 • Issue 2 • PP: 13 –27 • 2026

Drug Classification in Clinical Pharmacy: Principles, Applications, and Implications for Patient-Centered Care

Ahmed Abdelfatah 1*
1Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt
* Corresponding Author.
verified

Open Access & Copyright

© 2026 The Author(s). Published by ASPG. This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

Received: June 28, 2026 Revised: July 30, 2026 Accepted: September 07, 2026

Abstract

Drug classification in clinical pharmacy is increasingly important for organizing medication knowledge, supporting therapeutic decisions, and improving patient-centered pharmaceutical care. As healthcare data become more complex, traditional rule-based classification approaches may be insufficient for interpreting heterogeneous drugrelated information, including medication histories, molecular descriptors, clinical indicators, adverse-event records, prescription patterns, and patient-specific risk factors. This review examines how artificial intelligence, machine learning, deep learning, feature selection, optimization, and decision-support systems contribute to drug classification in clinical pharmacy. The review discusses the role of intelligent models in medication safety assessment, drug–drug interaction monitoring, personalized therapy, pharmacy-service planning, and operational medication management. It also highlights major challenges related to data quality, interpretability, generalizability, workflow integration, and ethical implementation. Overall, intelligent drug classification can strengthen clinical pharmacy practice when computational models are transparent, clinically meaningful, and aligned with professional pharmaceutical judgment.

Keywords

Artificial intelligence Drug classification Clinical pharmacy Machine learning Medication safety

References

[1] S. Zhang, “Drug usage classification based on personality and demographic features using a combination of sampling and machine learning algorithms,” Computer Methods in Biomechanics and Biomedical Engineering, pp. 1–22, 2025.

[2] M. Hammami, W. Yeddes, H. Gadhoumi, R. Yazidi, M. Saidani Tounsi, and K. Msaada, “Machine learningdriven bioavailability prediction in early-stage drug development: a KNIME-based computational workflow for digital health applications,” Xenobiotica, vol. 55, no. 5, pp. 339–348, 2025.

[3] J. Gu, Y. Xu, J. Sun, andW. Liu, “ADMET property prediction model based on feature selection and data mining techniques,” International Journal of Autonomous and Adaptive Communications Systems, vol. 18, no. 4, pp. 310–323, 2025.

[4] J. Song, M. Wei, S. Zhao, H. Zhai, Q. Dai, and X. Duan, “Drug sensitivity prediction based on multi-stage multimodal drug representation learning,” Interdisciplinary Sciences: Computational Life Sciences, vol. 17, no. 2, pp. 231–243, 2025.

[5] A. Singh, N. Prakash, and A. Jain, “Meta-Heuristic Optimization for the Multi-Classification of Chronic Disease: A Review With Machine Learning Perspectives,” WIREs Data Mining and Knowledge Discovery, vol. 15, no. 3, Art. no. e70030, 2025.

[6] H. Fakhouri, F. Hamad, M. Akhoirshida, and A. Al Hwaitat, “Advanced metaheuristics for feature selection and classification in medical datasets,” in 2025 1st International Conference on Computational Intelligence Approaches and Applications (ICCIAA). IEEE, pp. 1–8, 2025.

[7] S. Shafi and G. A. Ansari, “Heart Disease Prediction Using Machine Learning with Metaheuristic Feature Selection Approaches,” Biomedical Materials & Devices, 2025.

[8] K. Chansiri, J. S. McCrae, K. O. Courtney, and D. Cappello, “A machine learning approach to healthcare needs and barriers using the 100% community survey of access to SDOH services,” Frontiers in Public Health, vol. 13, Art. no. 1659322, 2025.

[9] H. Nabli, A. Ghannem, R. Ben Djemaa, and L. Sliman, “How innovative technologies shape the future of pharmaceutical supply chains,” Computers & Industrial Engineering, vol. 199, Art. no. 110745, 2025.

[10] S. Al-Hourani and D.Weraikat, “A systematic review of artificial intelligence (AI) and machine learning (ML) in pharmaceutical supply chain (PSC) resilience: Current trends and future directions,” Sustainability, vol. 17, no. 14, Art. no. 6591, 2025.

[11] K. Abbas, C. Hao, X. Yong, M. K. Hasan, S. Islam, and A. H. Abd Rahman, “Graph neural network-based drugdrug interaction prediction,” Scientific Reports, vol. 15, Art. no. 30340, 2025.

[12] Y. Dan, J. Ruan, Z. Zhu, and H. Yu, “Predicting the toxicity of drug molecules with selecting effective descriptors using a binary ant colony optimization (BACO) feature selection approach,” Molecules, vol. 30, no. 7, Art. no. 1548, 2025.

[13] E. Avuçlu, “Determining the most accurate machine learning algorithms for medical diagnosis using the monk’ problems database and statistical measurements,” Journal of Experimental & Theoretical Artificial Intelligence, vol. 37, no. 2, pp. 357–376, 2025.

[14] A. Salhi, R. Alshamrani, A. Althbiti, A. Ismail, M. Abd- ElRahman, and B. M. Hassan, “Optimizing high dimensional data classification with a hybrid AI driven feature selection framework and machine learning schema,” Scientific Reports, vol. 15, Art. no. 35038, 2025.

[15] A. Das, “Intelligent deep learning-based disease monitoring system in 5G network using multi-disease big data,” Journal of Biomolecular Structure and Dynamics, vol. 43, no. 12, pp. 5730–5755, 2025.

[16] A. S. Ghoneim, “Evolutionary Computing and Nature- Based Solutions for Personalized Health: Natural Inspirations for Wellness Optimisation,” in Harnessing AIand Machine Learning for Precision Wellness. IGI Global Scientific Publishing, pp. 243–298, 2025.

[17] R. Frieri, “D-optimal designs for comparative experiments when different models for the treatment effects are assumed in the competing arms,” Stat, vol. 14, no. 3, Art. no. e70082, 2025.

[18] I. Zidi, “A novel approach for dynamic ambulance routing: Integrating K-means++ clustering with time-variant multi-objective SPEA2,” Journal of Administrative and Economic Sciences, vol. 18, no. 2, pp. 619–642, 2025.

[19] D. Kumar, G. Soni, S. K. Mangla, Y. Kazancoglu, and A. P. S. Rathore, “A machine learning-based hybrid approach for maximizing supply chain reliability in a pharmaceutical supply chain,” Computers & Industrial Engineering, vol. 200, Art. no. 110834, 2025.

[20] G. Thamer Francis, A. Souri, and N. ˙Inanç, “A hybrid firefly-based attribute selection and split-point mechanism for securing software-defined industrial Internet of Things,” Journal of High Speed Networks, vol. 31, no. 3, pp. 228–243, 2025.

[21] G. Atteia, M. Alabdulhafith, H. A. Abdallah, N. Abdel Samee, and W. Alayed, “Deep learning-based decision support system for cervical cancer identification in liquid-based cytology pap smears,” Technology and Health Care, vol. 33, no. 5, pp. 2194–2210, 2025.

[22] P. P. Lokhande and K. Chinnaiah, “Heart Disease Detection and Prognosis Using IoT-Based ECG Sensor Data with Hybrid Deep Learning Architecture and Optimal Resource Allocation,” Cybernetics and Systems, vol. 56, no. 7, pp. 1002–1052, 2025.

[23] A. H. Sfayyih, N. Sulaiman, and A. H. Sabry, “Noninvasive diagnosis of lung diseases via multimodal feature extraction from breathing audio and chest dynamics,” Computers in Biology and Medicine, vol. 191, Art. no. 110182, 2025.

[24] A. Yaqoob, N. K. Verma, M. A. Mir, G. G. Tejani, N. H. B. Eisa, H. M. H. Osman, and M. A. Shah, “SGAdriven feature selection and random forest classification for enhanced breast cancer diagnosis: A comparative study,” Scientific Reports, vol. 15, Art. no. 10944, 2025.

[25] M. Rahiminia, S. Shahrabifarahani, M. Alipour-Vaezi, A. Aghsami, and F. Jolai, “A novel data-driven patient and medical waste queueing-inventory system under pandemic: a real-life case study,” International Journal of Production Research, vol. 63, no. 2, pp. 418–434, 2025.

[26] J.-Y. Yan, P.-W. Zhang, W.-G. Sheng, J.-P. Shi, W. Ni, L. Li, and Y.-J. Zheng, “Evolutionary fuzzy learning for Chinese medicine liver syndrome differentiation,” Systems Science & Control Engineering, vol. 13, no. 1, Art. no. 2507261, 2025.

[27] Y. Peng and W. Liao, “Inventory routing optimization for pharmaceutical cold chain logistics from economic and environmental perspective,” International Journal of Systems Science: Operations & Logistics, vol. 12, no. 1, Art. no. 2474690, 2025.

[28] K. Elloumi, A. Ammar, and M. Benaissa, “Particle swarm optimization algorithm for design of an adaptive Kanban system based on optimization via simulation,” Journal of Industrial and Production Engineering, vol. 42, no. 6, pp. 612–624, 2025.

[29] G. Mercadal-Orfila, J. Serrano López De Las Hazas, M. Riera-Jaume, and S. Herrera-Perez, “Developing a Prototype Machine Learning Model to Predict Quality of Life Measures in People Living With HIV,” Integrated Pharmacy Research and Practice, vol. 14, pp. 1–16, 2025.

Cite This Article

Choose your preferred format

format_quote
Abdelfatah, Ahmed. "Drug Classification in Clinical Pharmacy: Principles, Applications, and Implications for Patient-Centered Care." Metaheuristic Optimization Review, vol. 7, no. 2, 2026, pp. 13 –27. DOI: https://doi.org/10.54216/MOR.070202
Abdelfatah, A. (2026). Drug Classification in Clinical Pharmacy: Principles, Applications, and Implications for Patient-Centered Care. Metaheuristic Optimization Review, Volume 7(Issue 2), 13 –27. DOI: https://doi.org/10.54216/MOR.070202
Abdelfatah, Ahmed. "Drug Classification in Clinical Pharmacy: Principles, Applications, and Implications for Patient-Centered Care." Metaheuristic Optimization Review Volume 7, no. Issue 2 (2026): 13 –27. DOI: https://doi.org/10.54216/MOR.070202
Abdelfatah, A. (2026) 'Drug Classification in Clinical Pharmacy: Principles, Applications, and Implications for Patient-Centered Care', Metaheuristic Optimization Review, Volume 7(Issue 2), pp. 13 –27. DOI: https://doi.org/10.54216/MOR.070202
Abdelfatah A. Drug Classification in Clinical Pharmacy: Principles, Applications, and Implications for Patient-Centered Care. Metaheuristic Optimization Review. 2026;Volume 7(Issue 2):13 –27. DOI: https://doi.org/10.54216/MOR.070202
A. Abdelfatah, "Drug Classification in Clinical Pharmacy: Principles, Applications, and Implications for Patient-Centered Care," Metaheuristic Optimization Review, vol. Volume 7, no. Issue 2, pp. 13 –27, 2026. DOI: https://doi.org/10.54216/MOR.070202
policy

Publisher's Note

The statements, opinions, and data presented in this article are solely those of the author(s) and do not necessarily represent those of ASPG, the journal, or its editors. ASPG and the editors disclaim responsibility for any harm arising from the use of any ideas, methods, instructions, or products described in this article, to the fullest extent permitted by applicable law.

Digital Archive Ready